EXO Biologics SA
5.6 FTEEXO Biologics reported revenue of 0 € for the 2025 financial year (annual accounts filed with the NBB on 16 Jul 2026), with 5.6 full-time equivalents.
By total assets for 2025, EXO Biologics ranks among the 100 largest of the 993 companies in its sector (NACE 7210) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of EXO Biologics shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +275 % Headcount (avg FTE) -50 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
EXO Biologics's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | 0 € | ||||
| Net result | −€2.32m | ||||
| Equity | €2.93m | ||||
| Cash | 158,176 € | ||||
| EBITDA | −€1.17m | ||||
| Total assets | €11.7m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 16 Jul 2026
- Year ended 31 Dec 2024filed on 14 Jul 2025
- Year ended 31 Dec 2023filed on 16 Jul 2024
- Year ended 31 Dec 2022filed on 20 Jul 2023
- Year ended 31 Dec 2021filed on 06 Oct 2022
EXO Biologics's financial analysis
- Solvency25.0%sector median: 57.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of EXO Biologics
EXO Biologics's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0732.982.379
- VAT number
- BE0732982379
- Peppol
- Registered · 0208:0732982379 · as of 12 Nov 2026
- Legal form
- SA
- Incorporated
- 29 Aug 2019
- Registered office
- 4000 Liège
- Size
- Micro · 5.6 FTE
- Latest accounts
- 2025 · filed on 16 Jul 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
EXO Biologics (SA) has been based in Liège since 2019, active in: research and experimental development on biotechnology. For 2025, it reports revenue of 0 €, a net loss of €2.32m and equity of €2.93m. With 5.6 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 25.0%, below the median of its sector (57.9%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to EXO Biologics
Companies in the same business, of comparable size and area, outside its group.
- ConvEyXo Research and experimental development on natural sciences and engineering Charleroi · balance sheet €10.3m
- Aboleris Holdco Research and experimental development on natural sciences and engineering Charleroi · balance sheet €14.8m
- ATB Therapeutics Manufacture of basic pharmaceutical products Marche-en-Famenne · balance sheet €10.6m
- AstriVax Therapeutics Research and experimental development on natural sciences and engineering Leuven · balance sheet €12.5m
- Nanocyl Research and experimental development on natural sciences and engineering Sambreville · balance sheet €13.2m
- Etherna Immunotherapies Research and experimental development on natural sciences and engineering Niel · balance sheet €12.8m
- The Akkermansia Company Research and experimental development on natural sciences and engineering Mont-Saint-Guibert · balance sheet €16.9m
- Biotalys Research and experimental development on natural sciences and engineering Ghent · balance sheet €16.3m
Frequently asked questions about EXO Biologics
What is the revenue of EXO Biologics?
According to the 2025 annual accounts filed with the NBB, the revenue of EXO Biologics amounts to 0 €.
What is the VAT number of EXO Biologics?
In Belgium, the VAT number is the company number prefixed with BE: BE0732982379 for EXO Biologics, if the company is VAT-registered. Its company number (CBE) is 0732.982.379.
Where is the registered office of EXO Biologics?
According to the CBE register, the registered office of EXO Biologics is in 4000 Liège.
What is the equity of EXO Biologics?
At the close of the 2025 financial year, the equity of EXO Biologics amounts to 2,927,249 €, a solvency of 25.0% of total assets.
How many people work at EXO Biologics?
5.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages EXO Biologics?
The register lists 10 active mandates at EXO Biologics. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is EXO Biologics within its sector?
By total assets for 2025, EXO Biologics ranks among the 100 largest of the 993 companies in its sector (NACE 7210) in Belgium that filed accounts for that financial year.
The full file of EXO Biologics
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →